345 related articles for article (PubMed ID: 25460915)
1. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.
Tammemägi MC; Church TR; Hocking WG; Silvestri GA; Kvale PA; Riley TL; Commins J; Berg CD
PLoS Med; 2014 Dec; 11(12):e1001764. PubMed ID: 25460915
[TBL] [Abstract][Full Text] [Related]
2. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations.
Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y
EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900
[TBL] [Abstract][Full Text] [Related]
3. Deep Learning to Assess Long-term Mortality From Chest Radiographs.
Lu MT; Ivanov A; Mayrhofer T; Hosny A; Aerts HJWL; Hoffmann U
JAMA Netw Open; 2019 Jul; 2(7):e197416. PubMed ID: 31322692
[TBL] [Abstract][Full Text] [Related]
4. Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.
Callender T; Imrie F; Cebere B; Pashayan N; Navani N; van der Schaar M; Janes SM
PLoS Med; 2023 Oct; 20(10):e1004287. PubMed ID: 37788223
[TBL] [Abstract][Full Text] [Related]
5. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self-reporting as Indigenous and non-Indigenous.
Tammemägi MC; Cina K; Kitts AKB; Koop D; Petereit MA; Sargent M; Petereit DG
Cancer; 2023 Dec; 129(24):3894-3904. PubMed ID: 37807694
[TBL] [Abstract][Full Text] [Related]
7. Absolute lung cancer risk increases among individuals with >15 quit-years: Analyses to inform the update of the American Cancer Society lung cancer screening guidelines.
Landy R; Cheung LC; Young CD; Chaturvedi AK; Katki HA
Cancer; 2024 Jan; 130(2):201-215. PubMed ID: 37909885
[TBL] [Abstract][Full Text] [Related]
8. 5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study.
Luo YH; Luo L; Wampfler JA; Wang Y; Liu D; Chen YM; Adjei AA; Midthun DE; Yang P
Lancet Oncol; 2019 Aug; 20(8):1098-1108. PubMed ID: 31255490
[TBL] [Abstract][Full Text] [Related]
9. Interval lung cancers not detected on screening chest X-rays: How are they different?
Kvale PA; Johnson CC; Tammemägi M; Marcus PM; Zylak CJ; Spizarny DL; Hocking W; Oken M; Commins J; Ragard L; Hu P; Berg C; Prorok P
Lung Cancer; 2014 Oct; 86(1):41-6. PubMed ID: 25123333
[TBL] [Abstract][Full Text] [Related]
10. Lung Cancer Screening in Brazil Comparing the 2013 and 2021 USPSTF Guidelines.
Emmerick ICM; Campos MR; Castanheira D; Muzy J; Marques A; Arueira Chaves L; Sobreira da Silva MJ
JAMA Netw Open; 2023 Dec; 6(12):e2346994. PubMed ID: 38079172
[TBL] [Abstract][Full Text] [Related]
11. The performance of NLST screening criteria in Asian lung cancer patients.
Kumar V; Becker K; Zheng HX; Huang Y; Xu Y
BMC Cancer; 2015 Nov; 15():916. PubMed ID: 26582178
[TBL] [Abstract][Full Text] [Related]
12. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.
de Koning HJ; Meza R; Plevritis SK; ten Haaf K; Munshi VN; Jeon J; Erdogan SA; Kong CY; Han SS; van Rosmalen J; Choi SE; Pinsky PF; Berrington de Gonzalez A; Berg CD; Black WC; Tammemägi MC; Hazelton WD; Feuer EJ; McMahon PM
Ann Intern Med; 2014 Mar; 160(5):311-20. PubMed ID: 24379002
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Pinsky PF; Black A; Parnes HL; Grubb R; David Crawford E; Miller A; Reding D; Andriole G
Cancer Epidemiol; 2012 Dec; 36(6):e401-6. PubMed ID: 23000116
[TBL] [Abstract][Full Text] [Related]
14. Analysis of lung cancer risk model (PLCO
Lebrett MB; Balata H; Evison M; Colligan D; Duerden R; Elton P; Greaves M; Howells J; Irion K; Karunaratne D; Lyons J; Mellor S; Myerscough A; Newton T; Sharman A; Smith E; Taylor B; Taylor S; Walsham A; Whittaker J; Barber PV; Tonge J; Robbins HA; Booton R; Crosbie PAJ
Thorax; 2020 Aug; 75(8):661-668. PubMed ID: 32631933
[TBL] [Abstract][Full Text] [Related]
15. A qualitative study of lung cancer risk perceptions and smoking beliefs among national lung screening trial participants.
Park ER; Streck JM; Gareen IF; Ostroff JS; Hyland KA; Rigotti NA; Pajolek H; Nichter M
Nicotine Tob Res; 2014 Feb; 16(2):166-73. PubMed ID: 23999653
[TBL] [Abstract][Full Text] [Related]
16. Benefit-to-radiation-risk of low-dose computed tomography lung cancer screening.
Hendrick RE; Smith RA
Cancer; 2024 Jan; 130(2):216-223. PubMed ID: 37909872
[TBL] [Abstract][Full Text] [Related]
17. Estimating the Effectiveness of Kidney Cancer Screening Within Lung Cancer Screening Programmes: A Validation in UK Biobank.
Harrison H; Wood A; Pennells L; Rossi SH; Callister M; Cartledge J; Stewart GD; Usher-Smith JA
Eur Urol Oncol; 2023 Jun; 6(3):351-353. PubMed ID: 37003861
[TBL] [Abstract][Full Text] [Related]
18. Screening Criteria Evaluation for Expansion in Pulmonary Neoplasias (SCREEN).
Huo B; Manos D; Xu Z; Matheson K; Chun S; Fris J; Wallace AMR; French DG
Semin Thorac Cardiovasc Surg; 2023 Winter; 35(4):769-780. PubMed ID: 35878739
[TBL] [Abstract][Full Text] [Related]
19. Mortality outcomes of low-dose computed tomography screening for lung cancer in urban China: a decision analysis and implications for practice.
Wang Z; Han W; Zhang W; Xue F; Wang Y; Hu Y; Wang L; Zhou C; Huang Y; Zhao S; Song W; Sui X; Shi R; Jiang J
Chin J Cancer; 2017 Jul; 36(1):57. PubMed ID: 28709441
[TBL] [Abstract][Full Text] [Related]
20. Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk.
Berrington de González A; Kim KP; Berg CD
J Med Screen; 2008; 15(3):153-8. PubMed ID: 18927099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
